There are 108 resources available
LBA44 - Lenvatinib (len) plus pembrolizumab (pembro) for advanced melanoma (MEL) that progressed on a PD-1 or PD-L1 inhibitor: Initial results of LEAP-004
Presenter: Ana Maria Arance Fernandez
Session: Proffered Paper - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
LBA45 - First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)
Presenter: Paolo Ascierto
Session: Proffered Paper - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA15 and LBA16
Presenter: Lisa Carey
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lisa Carey
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Webcast
Invited Discussant LBA17, LBA18 and 273O
Presenter: Fatima Cardoso
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lisa Carey
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Webcast
Invited Discussant LBA43, LBA44 and LBA45
Presenter: Bartosz Chmielowski
Session: Proffered Paper - Melanoma and other skin tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: James Larkin
Session: Proffered Paper - Melanoma and other skin tumours
Resources:
Webcast
Invited Discussant LBA46 and 1076O
Presenter: Rodabe Amaria
Session: Proffered Paper - Melanoma and other skin tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: James Larkin
Session: Proffered Paper - Melanoma and other skin tumours
Resources:
Webcast